About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
BOARD MEETINGS
Board
Meetings
Alkem Laboratories Ltd.
From Date
:
To Date
:
Source Date
Board Meeting Date
Details
28-Jan-2025
07-Feb-2025
Quarterly Results & Interim Dividend
05-Nov-2024
13-Nov-2024
Quarterly Results
25-Jul-2024
09-Aug-2024
Quarterly Results
16-May-2024
29-May-2024
Audited Results & Final Dividend
01-Feb-2024
09-Feb-2024
Interim Dividend & Quarterly Results
27-Oct-2023
07-Nov-2023
Quarterly Results
31-Jul-2023
10-Aug-2023
Quarterly Results
09-May-2023
19-May-2023
Final Dividend & Audited Results
24-Jan-2023
10-Feb-2023
Quarterly Results & Interim Dividend
02-Nov-2022
11-Nov-2022
Quarterly Results
25-Jul-2022
05-Aug-2022
Quarterly Results
28-Apr-2022
13-May-2022
Audited Results & Final Dividend
24-Jan-2022
04-Feb-2022
Interim Dividend & Quarterly Results
02-Nov-2021
12-Nov-2021
Quarterly Results
26-Jul-2021
06-Aug-2021
Quarterly Results
14-May-2021
25-May-2021
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2021 ,inter alia, to consider and approve (i) to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2021; and (ii) to consider and recommend Final Dividend, if any, for the financial year ended 31st March, 2021. Kindly take note of the same.
27-Jan-2021
05-Feb-2021
Quarterly Results & Interim Dividend
28-Oct-2020
06-Nov-2020
Quarterly Results
27-Jul-2020
07-Aug-2020
Quarterly Results
26-May-2020
05-Jun-2020
Audited Results & Final Dividend
Page
1
of
2
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.